SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-01-13 16:11
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$12,482
+11,666 vol
$1.07 each
38,334
Filed 2024-01-13 16:10
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-12,482.62
-11,666 vol
$1.07 each
1,666
Filed 2023-11-18 15:25
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,733
+1,667 vol
$1.04 each
26,668
Filed 2023-11-18 15:24
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-1,733.68
-1,667 vol
$1.04 each
13,332
Filed 2023-09-15 18:29
Tx date 2023-09-12
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
20,000
Filed 2023-01-14 16:02
Tx date 2023-01-11
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$6,883
+11,667 vol
$0.59 each
25,001
Filed 2023-01-14 16:01
Tx date 2023-01-11
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-6,883.53
-11,667 vol
$0.59 each
14,999
Filed 2022-11-19 13:20
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$800.16
+1,667 vol
$0.48 each
13,334
Filed 2022-11-19 13:19
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-800.16
-1,667 vol
$0.48 each
26,666
Filed 2022-11-19 13:15
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+5,000 vol
5,000
Filed 2022-11-19 13:13
Tx date 2020-11-24
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-13 14:10
Tx date 2022-01-11
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+11,667 vol
11,667
Filed 2022-01-13 14:10
Tx date 2020-11-24
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-13 14:09
Tx date 2022-01-11
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-11,667 vol
28,333
Filed 2021-11-19 20:29
Tx date 2021-11-15
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+5,000 vol
40,000
Filed 2021-01-15 21:39
Tx date 2021-01-11
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+35,000 vol
35,000
Filed 2021-01-15 21:39
Tx date 2020-11-24
$ATE
Antibe Therapeutics Inc.
McNealey, Jennifer
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report